Brickell Biotech Company
Brickell Biotech is a pharmaceutical company that specializes in creating prescription drugs for skin diseases. Their main focus is on developing a drug called sofpironium bromide, which is used to treat hyperhidrosis.
Founded Date:
2009
Technology:
Biotechnology, Health Care, Therapeutics
Funding Status:
IPO
Total Funding:
33464587.0
Employee Number:
11-50
Headquarters:
Miami, Florida, United States
Last Funding Date:
2021-07-19
Investors Number:
3.0
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$1M to $10M
Acquisitions Number:
1
Industry:
End-to-End Drug Development